- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Westminster Today
By the People, for the People
Oramed Pharmaceuticals and TriSalus Life Sciences Compared
Two small-cap medical companies vie for investor attention
Published on Feb. 8, 2026
Got story updates? Submit your updates here. ›
Oramed Pharmaceuticals (NASDAQ:ORMP) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which one is the better investment? The article compares the two companies across various factors like profitability, risk, valuation, and analyst recommendations to determine the superior stock.
Why it matters
This comparison is relevant for investors looking to gain exposure to the medical technology and pharmaceutical sectors, as it provides an in-depth analysis of two lesser-known but potentially promising small-cap companies in this space.
The details
The analysis finds that TriSalus Life Sciences has a lower price-to-earnings ratio and a stronger consensus rating from analysts, suggesting it may be the more favorable investment compared to Oramed Pharmaceuticals. However, Oramed Pharmaceuticals has higher earnings per share and a more diversified product portfolio, which could make it an attractive option for some investors.
- The article was published on February 8, 2026.
The players
TriSalus Life Sciences
A medical technology company that researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer.
Oramed Pharmaceuticals
A pharmaceutical company that engages in the research and development of solutions for the treatment of diabetes and the use of orally ingestible capsules for delivery of polypeptides.
The takeaway
This comparison highlights the nuances between two small-cap medical companies, Oramed Pharmaceuticals and TriSalus Life Sciences, and the factors investors should consider when evaluating which one may be the superior investment opportunity.
